Hinge Health (NYSE:HNGE) CFO Sells $2,116,639.83 in Stock

Hinge Health Inc. (NYSE:HNGE) CFO James Budge sold 44,589 shares of the company’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $47.47, for a total transaction of $2,116,639.83. Following the completion of the sale, the chief financial officer directly owned 479,878 shares in the company, valued at approximately $22,779,808.66. The trade was a 8.50% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Hinge Health Stock Up 2.7%

HNGE traded up $1.26 during midday trading on Tuesday, reaching $48.27. 1,104,332 shares of the company’s stock were exchanged, compared to its average volume of 2,426,225. The company’s 50-day moving average is $49.26. Hinge Health Inc. has a one year low of $33.42 and a one year high of $62.18.

Hinge Health (NYSE:HNGE) last issued its earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.18. The company had revenue of $154.21 million during the quarter, compared to analyst estimates of $142.44 million. Hinge Health’s revenue was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health declared that its Board of Directors has initiated a share buyback plan on Wednesday, November 12th that authorizes the company to buyback $250.00 million in shares. This buyback authorization authorizes the company to repurchase up to 7.2% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Hedge Funds Weigh In On Hinge Health

Several large investors have recently made changes to their positions in HNGE. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Hinge Health in the third quarter worth about $37,000. Montag A & Associates Inc. acquired a new stake in shares of Hinge Health during the 2nd quarter worth approximately $41,000. SBI Securities Co. Ltd. bought a new stake in shares of Hinge Health during the second quarter worth approximately $48,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Hinge Health during the third quarter worth approximately $49,000. Finally, Jones Financial Companies Lllp boosted its stake in Hinge Health by 348.0% in the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock valued at $54,000 after acquiring an additional 870 shares during the last quarter.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on HNGE shares. Barclays upped their target price on shares of Hinge Health from $62.00 to $65.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Morgan Stanley boosted their target price on Hinge Health from $57.00 to $67.00 and gave the stock an “overweight” rating in a report on Tuesday, September 23rd. JMP Securities increased their price target on Hinge Health from $58.00 to $65.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 6th. Bank of America lifted their price objective on Hinge Health from $42.00 to $64.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Finally, Needham & Company LLC increased their target price on Hinge Health from $47.00 to $59.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $59.93.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.